Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Anesthesia and Analgesia|August 25, 2007
The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparationsSebastian N Stehr, Torsten Christ, Berit Rasche, et al.
Heart Rhythm|October 13, 2015
The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillationJohn Ford, James Milnes, Said El Haou, et al.
The International Journal of Biochemistry & Cell Biology|March 6, 2012
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channelsDiego Cotella, Susanne Radicke, Valentina Cipriani, et al.
Cardiovascular Research|August 1, 2006
Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing heartsSusanne Radicke, Diego Cotella, Eva Maria Graf, et al.
The Journal of Physiology|October 28, 2003
Electrophysiological properties of human mesenchymal stem cellsJürgen F Heubach, Eva M Graf, Judith Leutheuser, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 16, 2004
An aqueous extract of the marine sponge Ectyoplasia ferox stimulates L-type Ca2+-current by direct interaction with the Cav1.2 subunitTorsten Christ, Melinda Wüst, Jan Matthes, et al.
International Journal of Cardiology|January 15, 2019
DPP10 is a new regulator of Nav1.5 channels in human heartFabian Belau, Katharina Metzner, Torsten Christ, et al.
European Journal of Pharmacology|May 10, 2011
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparationsTamás Szél, István Koncz, Norbert Jost, et al.
Circulation|April 7, 2004
KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased heartsMin Jiang, Mei Zhang, Daniel G Tang, et al.
Cardiovascular Research|January 24, 2013
The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillationErich Wettwer, Torsten Christ, Sebastian Endig, et al.
Pageof 5